Cigna Group Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Cigna Group ha aumentado sus beneficios a una tasa media anual de 3.9%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 5.6% anual. Los ingresos han ido creciendo a una tasa media de 10.5% al año. La rentabilidad financiera de Cigna Group es de 9.3%, y sus márgenes netos son de 1.8%.

Información clave

3.9%

Tasa de crecimiento de los beneficios

7.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	10.5%
Rentabilidad financiera	9.3%
Margen neto	1.8%
Próxima actualización de resultados	01 Aug 2024

Actualizaciones de resultados anteriores recientes

Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

May 09

Recent updates

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

Apr 18

Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why

Apr 09

Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Apr 05

Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018

Apr 01

Cigna: Trimming The Fat And Staying Focused

Mar 05

Cigna: Big Buybacks And Total Return Potential

Feb 26

Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40

Feb 05

Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap

Jan 29

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

Jan 25

Why Dividend Growth Investors Should Buy Cigna

Jan 18

It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)

Jan 09

Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital

Dec 25

Cigna: Sentiment And Fundamentals On Their Side

Dec 21

Cigna's Merger Fumble: A Festive Financial Rebound

Dec 11

Humana And Cigna Topple On Rumors Of An Unlikely Union

Nov 30

Cigna Delivering Growth At A Great Price

Nov 13

Cigna: Too Cheap To Ignore

Oct 24

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

Oct 06

Cigna: Buy Rating Driven By Undervaluation & Revenue Growth

Oct 01

Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return

Sep 21

Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape

Sep 14

Cigna Group: Weaker Than Peers But Still A Buy

Aug 27

Cigna: Buy During The Next Correction (Technical Analysis)

Aug 08

Cigna Group (NYSE:CI) Has A Pretty Healthy Balance Sheet

Jul 02

Cigna: Buy While It's Still Cheap And Not Loved

Jun 29

If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity

Jun 18

Cigna: Buy This Value Gem Before It Bounces Back

Jun 12

Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture

Jun 04

Cigna: Many Reasons To Invest

May 29

An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued

May 21

Is Cigna Group (NYSE:CI) A Risky Investment?

Mar 24

Cigna Corporation: Undervalued For Stable Growth

Feb 23

Do Cigna's (NYSE:CI) Earnings Warrant Your Attention?

Feb 21

Cigna (NYSE:CI) Will Pay A Larger Dividend Than Last Year At $1.23

Feb 06

CIGNA Q4 2022 Earnings Preview

Feb 02

Cigna Corporation Is At A Great Entry Price

Jan 18

Cigna: A Defensive Stock With Multiple Avenues For Growth

Jan 11

Here's Why Cigna (NYSE:CI) Can Manage Its Debt Responsibly

Dec 21

Desglose de ingresos y gastos

Cómo gana y gasta dinero Cigna Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:CI Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Mar 24	204,145	3,620	14,496
31 Dec 23	195,187	5,164	14,370
30 Sep 23	189,856	5,292	14,062
30 Jun 23	186,021	6,641	13,621
31 Mar 23	182,808	6,774	13,421
31 Dec 22	180,031	6,704	13,110
30 Sep 22	180,028	6,627	13,042
30 Jun 22	179,185	5,491	12,999
31 Mar 22	176,986	5,401	12,748
31 Dec 21	174,267	5,370	12,791
30 Sep 21	170,397	8,384	13,296
30 Jun 21	167,028	8,151	13,402
31 Mar 21	163,141	8,438	13,697
31 Dec 20	160,550	8,458	13,660
30 Sep 20	157,009	5,300	13,329
30 Jun 20	154,629	5,263	13,467
31 Mar 20	154,168	4,917	13,332
31 Dec 19	153,743	5,104	13,315
30 Sep 19	129,660	4,271	12,391
30 Jun 19	102,510	3,692	12,107
31 Mar 19	75,145	3,090	11,651
31 Dec 18	48,569	2,637	11,141
30 Sep 18	44,969	2,759	18,350
30 Jun 18	44,001	2,547	15,343
31 Mar 18	42,949	2,554	12,639
31 Dec 17	42,043	2,237	9,830
30 Sep 17	41,332	2,353	54
30 Jun 17	40,723	2,249	0
31 Mar 17	40,258	1,946	0
31 Dec 16	40,007	1,867	9,750
30 Sep 16	39,252	1,911	0
30 Jun 16	38,761	2,002	0
31 Mar 16	38,293	2,080	0
31 Dec 15	37,876	2,094	0
30 Sep 15	37,276	2,135	0
30 Jun 15	36,644	2,122	0
31 Mar 15	35,885	2,107	0
31 Dec 14	34,914	2,102	0
30 Sep 14	34,098	1,996	0
30 Jun 14	33,407	2,015	0
31 Mar 14	32,654	1,947	0
31 Dec 13	32,380	1,476	0
30 Sep 13	31,888	1,521	0

Ingresos de calidad: CI tiene una única gran pérdida de $2.1B que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio(1.8%) de CI son inferiores a los del año pasado (3.7%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de CI han crecido un 3.9% al año en los últimos 5 años.

Acelerando crecimiento: CI ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: CI tuvo un crecimiento negativo de los beneficios (-46.6%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (15.1%).

Cigna Group Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Información clave

Actualizaciones de resultados anteriores recientes

The Cigna Group to Report Q3, 2024 Results on Oct 31, 2024

Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Cigna Group to Report Q2, 2024 Results on Aug 01, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Cigna: Game Over For PBMs?

Executive VP notifies of intention to sell stock

Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet

Cigna: Will Benefit From Lower Medicaid Enrollments

Upcoming dividend of US$1.40 per share

The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing

The Cigna Group to Report Q3, 2024 Results on Oct 31, 2024

Insider notifies of intention to sell stock

Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now

Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

Consensus EPS estimates fall by 16%

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Fourth quarter dividend of US$1.40 announced

The Cigna Group Declares Quarterly Dividend, Payable on June 20, 2024

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

National Center for Public Files an Exempt Solicitation Statement and Request Vote for the Proposal

Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why

Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018

President notifies of intention to sell stock

The Cigna Group, Annual General Meeting, Apr 24, 2024

Cigna: Trimming The Fat And Staying Focused

Upcoming dividend of US$1.40 per share

Cigna: Big Buybacks And Total Return Potential

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40

Third quarter dividend increased to US$1.40

Insider notifies of intention to sell stock

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

The Cigna Group Declares Cash Quarterly Dividend, Payable on March 21, 2024

Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

the Cigna Group Announces Intention to Retire of Mary Agoglia Hoeltzel as Senior Vice President and Chief Accounting Officer, Effective from July 1, 2024

Why Dividend Growth Investors Should Buy Cigna

The Cigna Group Announces Management Changes

It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)

Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital

Cigna: Sentiment And Fundamentals On Their Side

Insider notifies of intention to sell stock

Investor sentiment improves as stock rises 17%

Cigna's Merger Fumble: A Festive Financial Rebound

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana And Cigna Topple On Rumors Of An Unlikely Union

Cigna and Humana Reportedly in Merger Talks

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Upcoming dividend of US$1.23 per share at 1.7% yield

The Cigna Group to Report Q2, 2024 Results on Aug 01, 2024

Cigna Delivering Growth At A Great Price

Cigna Reportedly Explores Shedding Medicare Advantage Business

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Cigna Group Declares Quarterly Dividend, Payable on December 21, 2023

Cigna: Too Cheap To Ignore

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

Cigna Healthcare Expands 2024 Medicare Advantage Plans Offering Customers More Variety and Value

Cigna: Buy Rating Driven By Undervaluation & Revenue Growth

Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return

The Cigna Group to Report Q1, 2024 Results on May 02, 2024

Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape

Cigna Healthcare Launches New Global Health Benefits Plan for Adults Aged 60+

Insider notifies of intention to sell stock

Upcoming dividend of US$1.23 per share at 1.8% yield

Cigna Group: Weaker Than Peers But Still A Buy

Executive VP & General Counsel notifies of intention to sell stock

Insider recently sold US$2.3m worth of stock

Insider notifies of intention to sell stock

Cigna: Buy During The Next Correction (Technical Analysis)

Second quarter 2023 earnings released: EPS: US$4.96 (vs US$4.95 in 2Q 2022)